Medikit Co.,Ltd. (TYO:7749)

Medikit Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	19,994	20,952	21,559	23,611	27,592	28,118
Cash & Short-Term Investments	19,994	20,952	21,559	23,611	27,592	28,118
Cash Growth	-1.75%	-2.82%	-8.69%	-14.43%	-1.87%	2.28%
Receivables	5,387	5,111	5,059	5,285	5,691	5,004
Inventory	5,615	5,481	4,567	3,877	3,281	3,626
Restricted Cash	1,500	1,500	1,500	1,500	1,500	1,500
Other Current Assets	290	171	558	218	112	293
Total Current Assets	32,786	33,215	33,243	34,491	38,176	38,541
Property, Plant & Equipment	14,889	14,943	14,447	11,474	10,438	10,834
Long-Term Investments	2,193	2,058	1,237	1,248	1,077	1,136
Goodwill	1,848	1,902	2,120	2,337	1,935	-
Other Intangible Assets	1,017	1,051	1,163	1,138	1,157	126
Long-Term Deferred Tax Assets	121	101	259	310	402	419
Other Long-Term Assets	1	2	1	1	1	1
Total Assets	52,855	53,272	52,470	50,999	53,186	51,057

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	2,757	2,607	3,469	3,180	2,545	2,575
Accrued Expenses	220	419	423	412	413	397
Current Portion of Leases	4	5	-	-	-	-
Current Income Taxes Payable	837	806	866	897	765	604
Other Current Liabilities	1,213	1,476	1,401	1,229	950	838
Total Current Liabilities	5,031	5,313	6,159	5,718	4,673	4,414
Long-Term Leases	13	13	-	-	-	-
Pension & Post-Retirement Benefits	-	-	-	-	86	84
Long-Term Deferred Tax Liabilities	327	332	340	336	330	-
Other Long-Term Liabilities	839	834	816	817	806	788
Total Liabilities	6,210	6,492	7,315	6,871	5,895	5,286

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	1,241	1,241	1,241	1,241	1,241	1,241
Additional Paid-In Capital	8,385	8,385	8,378	8,432	10,384	10,378
Retained Earnings	38,757	38,957	37,340	39,826	38,519	37,165
Treasury Stock	-2,929	-2,929	-2,545	-6,046	-3,243	-3,256
Comprehensive Income & Other	1,191	1,126	741	675	390	243
Shareholders' Equity	46,645	46,780	45,155	44,128	47,291	45,771
Total Liabilities & Equity	52,855	53,272	52,470	50,999	53,186	51,057

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	17	18	-	-	-	-
Net Cash (Debt)	19,977	20,934	21,559	23,611	27,592	28,118
Net Cash Growth	-1.79%	-2.90%	-8.69%	-14.43%	-1.87%	2.28%
Net Cash Per Share	1374.73	1437.18	1463.41	1445.78	1643.95	1673.59
Filing Date Shares Outstanding	14.48	14.48	14.62	14.8	16.79	16.78
Total Common Shares Outstanding	14.48	14.48	14.62	14.8	16.79	16.78
Working Capital	27,755	27,902	27,084	28,773	33,503	34,127
Book Value Per Share	3221.77	3231.09	3089.51	2982.53	2817.14	2727.96
Tangible Book Value	43,780	43,827	41,872	40,653	44,199	45,645
Tangible Book Value Per Share	3023.88	3027.13	2864.88	2747.66	2632.95	2720.45

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 23, 2026

Data Sources Report a data error